ClinicalTrials.gg
CompletedNCT01628497Updated Apr 7, 2017

Exhaled NO Testing in Filariasis

An observational study in Filariasis, sponsored by Vanderbilt University Medical Center. Completed at 1 site in Guyana. Open to participants aged 6 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-04-07.

Sponsored by Vanderbilt University Medical Center · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
96
Ages
6 Years and older
Sex
All
01

Study summary

This study is looking at the difference in exhaled nitric oxide levels in patients with and without laboratory evidence of filariasis.

02

Conditions studied

  • Filariasis

Browse trials for

03

In context

Filariasis

23 studies on the registry are indexed under Filariasis; 2 are open to participants now.

Browse Filariasis studies →

Lead sponsor

Vanderbilt University Medical Center is the lead sponsor of 833 studies on the registry; 155 are open to participants now.

Of its 125 completed or terminated interventional studies of FDA-regulated products, 92 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Study subjects:

  • recruited from patients with a chief complaint of wheezing, asthma or cough.
  • assessed by a physician prior to consideration for enrollment into the study
  • screened by the study investigator after evaluation by the physician

Control subjects:

Controls will be matched with cases by gender, age and region of residence. They will have non-emergent complaints without respiratory symptoms.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 6 years or older of either gender
  2. Patients presenting with pulmonary symptoms a. Confirmed or suspected asthma patients: i. Patients presenting with symptoms consistent with an acute exacerbation of asthma, including:
  1. Wheezing 2. Shortness of breath 3. Chest tightness 4. Cough ii. Disposition to the asthma room after triage and physician evaluation (disposition to other areas of the A\&E allowed if due to no available space in the asthma room) iii. Patients are potentially eligible with or without a past history of health care provider diagnosed asthma iv. Patients are potentially eligible regardless of the number of previous episodes of wheezing (i.e. patients with a first episode of bronchospasm are potentially eligible) v. If suspected or documented to have pneumonia or a pulmonary infiltrate, patients are potentially eligible if:
  1. They have a dry cough (no production of purulent sputum)
  2. They have bronchospasm as manifested by wheezing or need for salbutamol (albuterol) breathing treatments vi. Patients with wheezing are not eligible if they:
  1. Have purulent sputum production 2. Have known or suspected:

a. Tuberculosis b. Immunodeficiency c. Congestive heart failure d. Foreign body aspiration b. Patients presenting with a chief complaint of cough: i. Potentially eligible patients will have a cough of greater than one week (seven days) duration ii. Asthma room disposition is not required for these subjects iii. If suspected or documented to have pneumonia or a pulmonary infiltrate, patients are potentially eligible if:

  1. They have a dry cough (no production of purulent sputum) iv. Patients with cough are not eligible if:
  1. Have purulent sputum production
  2. Have known or suspected:

    1. Tuberculosis
    2. Immunodeficiency
    3. Congestive heart failure
    4. Foreign body aspiration
  3. Patients will be medically stable at the time of the consent process (see exclusion criteria below)
  4. A minimum of 2 years of continuous residence in Guyana at the time of enrollment, exclusive of short trips out of the country (at least 21 of previous 24 months physically in Guyana)
  5. English speaking

Exclusion criteria

Exclusion Criteria:

  1. Patients less than 6 years of age
  2. Patients who do not consent to the study
  3. Children (\<18 years) without a parent/guardian present
  4. Prisoners
  5. Patients who appear to be medically or psychologically unstable or felt to be otherwise inappropriate for study enrollment, in the opinion of the investigator or any treating health care provider. This determination will be made on an individual basis, but some of the general criteria to be used in making this determination will be:

    i. The patient appears to be in significant pain ii. The patient appears acutely ill - severe respiratory distress, diaphoretic, altered mental status, active bleeding, actively vomiting, etc.

    iii. Those with respiratory difficulty to the point they cannot speak in complete sentences iv. Chief complaint of sexual assault v. The patient appears acutely intoxicated vi. The patient displays agitated, nervous, restless, or other behavior suggestive of an uncontrolled psychiatric emergency

  6. Patients with pulmonary findings felt to be secondary to congestive heart failure, foreign body, bacterial pneumonia, tuberculosis or other clearly defined cause
  7. Non-English speaking patients
  8. Patients without at least 2 years of residence (exclusive of short trips abroad, total of 21 of 24 previous months physically in Guyana) in Guyana at the time of enrollment
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
96 participants (actual)

Groups and cohorts

  • Positive filariasis test

    Those testing positive for filariasis

  • Filariasis negative
06

Study locations

1 site
  • Georgetown Public Hospital Corporation
    Georgetown, Region 4, Guyana
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01628497
Responsible party
Sponsor
First posted
Jun 26, 2012
Start date
May 2012
Primary completion
Mar 2014
Completion
Mar 2014
Last update
Apr 7, 2017

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion